According to a release issued by Ranbaxy to the BSE today, "RPI was commended for consistency of products and programs provided to Wal-Mart, which has fulfilled the requests of Wal-Mart customers."
RPI is based in Jacksonville, Florida, and is engaged in the sale and distribution of generic and branded prescription products in the US.
